HE 10Alternative Names: HE 10 - Huons; HU-004
Latest Information Update: 22 Jul 2015
At a glance
- Originator Huons
- Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
- Mechanism of Action Mitochondrial permeability transition pore inhibitors; P-glycoprotein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Dry eyes